Serum Institute of India & Bharat Biotech pledge to provide smooth Covid-19 vaccine roll-out

Bharat Biotech and Serum Institute of India (SII) on Tuesday issued a joint statement saying they had pledged to ensure a smooth roll-out of Covid-19 vaccines to India and the world.

Both the vaccine makers on Tuesday communicated their combined intent to develop, manufacture and supply Covid-19 vaccines.

“We are fully aware of the importance of vaccines for people and countries alike, we hereby communicate our joint pledge to provide global access for our Covid-19 vaccines,” the statement read.

“I would like to clarify two matters: as there is confusion in the public domain, exports of vaccines are permitted to all countries and a joint public statement clearing up any recent miscommunication with regards to Bharat Biotech will be made,” Adar Poonawalla tweeted.

Minutes after the joint statement was made public, Bharat Biotech also tweeted the same statement from its official twitter handle: @BharatBiotech.

On Sunday, both the companies were granted restricted emergency-use authorisation for sale of their Covid-19 vaccine in India by the Drugs Controller General of India.

We are fully aware of the importance of vaccines for people and countries alike, we hereby communicate our joint pledge to provide global access for our COVID-19 vaccines: Joint statement of Serum Institute of India and Bharat Biotech

— ANI (@ANI) January 5, 2021